Pharma Capital
Showing 40 of 41
Name Market Market Cap Share Price Daily Share Movement
abzena-logo.png Abzena plc AIM £105.75m £0.50 0.00% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £12.75m £0.16 0.00% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £7.34m £0.83 -5.71% ico_glass.png
allergytherap.gif Allergy Therapeutics plc AIM £170.81m £0.29 0.00% ico_glass.png
Alliance-logo.png Alliance Pharma plc AIM £243.08m £0.51 -9.29% ico_glass.png
Amryt_Pharma_59677939c44cb.png Amryt Pharmaceuticals AIM £46.36m £0.22 -2.20% ico_glass.png
angle-logo.png ANGLE plc AIM £35.16m £0.47 -1.05% ico_glass.png
avacta.png Avacta Group Plc AIM £55.40m £0.81 -2.41% ico_glass.png
c4x.png C4X Discovery Holdings plc AIM £40.97m £0.88 0.00% ico_glass.png
clinigen-logo.png Clinigen Group PLC AIM £1,141.76m £9.92 -0.80% ico_glass.png
collagen_solutions.png Collagen Solutions PLC AIM £16.24m £0.05 -2.44% ico_glass.png
concepta.png Concepta AIM £12.33m £0.11 -1.10% ico_glass.png
deltex-logo.png Deltex Medical Group plc AIM £10.76m £0.04 0.00% ico_glass.png
e-ther.png e-Therapeutics plc AIM £32.89m £0.12 0.00% ico_glass.png
Ergomed-logo.png Ergomed Plc AIM £78.15m £1.93 0.00% ico_glass.png
fr.png Faron Pharmaceuticals Oy AIM £196.10m £7.03 0.36% ico_glass.png
FuturaMedical-Logo-1row-RGB.jpg Futura Medical plc. AIM £65.16m £0.54 0.00% ico_glass.png
genedrive_logo.png Genedrive PLC AIM £7.94m £0.43 0.00% ico_glass.png
Horizon-logo.2.png Horizon Discovery Group PLC AIM £247.22m £2.56 0.00% ico_glass.png
imm.gif ImmuPharma PLC AIM £76.70m £0.58 0.22% ico_glass.png
ID_LOGO.png InnovaDerma LSE £43.36m £3.45 1.77% ico_glass.png
ixico-logo.png IXICO Plc AIM £10.03m £0.37 15.63% ico_glass.png
MaxCyte.gif MaxCyte AIM £124.55m £2.45 0.00% ico_glass.png
Midatech_pharma.png Midatech Pharma Plc AIM £50.40m £1.04 0.00% ico_glass.png
motif-bio-logo-2.png Motif Bio Plc AIM £55.83m £0.29 -0.44% ico_glass.png
nanobiotix_logo.png Nanobiotix SA EPA £- £- - ico_glass.png
netscientific-logo.png Netscientific PLC AIM £31.07m £0.45 0.00% ico_glass.png
optibiotix-logo-2.png OptiBiotix Health plc AIM £52.62m £0.67 0.75% ico_glass.png
redx-logo.png Redx Pharma Plc AIM £40.95m £0.32 -1.52% ico_glass.png
reneuron_logo.png ReNeuron Group Plc AIM £54.59m £0.02 -1.43% ico_glass.png
rex_bionics_logo.png Rex Bionics PLC AIM £0.45m £0.02 -30.00% ico_glass.png
sar.jpg Sareum Holdings Plc AIM £20.50m £0.01 0.00% ico_glass.png
scancell.gif Scancell Holdings Plc AIM £34.33m £0.11 -1.12% ico_glass.png
silence-logo-2.jpg Silence Therapeutics plc AIM £94.49m £1.35 0.75% ico_glass.png
skinbio_therapeutics.png SkinBioTherapeutics PLC AIM £10.98m £0.09 0.00% ico_glass.png
sphere_medical_sponsor_logo.gif Sphere Medical Holding PLC AIM £8.68m £0.06 0.00% ico_glass.png
summit_corp_logo.png Summit Therapeutics PLC AIM £125.36m £2.03 3.85% ico_glass.png
synairgen-latest.jpg Synairgen plc AIM £7.08m £0.08 3.33% ico_glass.png
tissue_regenix_sponsor_logo.png Tissue Regenix Group PLC AIM £83.76m £0.11 0.00% ico_glass.png
Valirx-logo.png ValiRx Plc AIM £2.98m £0.02 0.00% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.